Abstract

Highly efficient gene conversion systems have the potential to facilitate the study of complex genetic traits using laboratory mice and, if implemented as a "gene drive," to limit loss of biodiversity and disease transmission caused by wild rodent populations. We previously showed that such a system of gene conversion from heterozygous to homozygous after a sequence targeted CRISPR/Cas9 double-strand DNA break (DSB) is feasible in the female mouse germline. In the male germline, however, all DSBs were instead repaired by end joining (EJ) mechanisms to form an "insertion/deletion" (indel) mutation. These observations suggested that timing Cas9 expression to coincide with meiosis I is critical to favor conditions when homologous chromosomes are aligned and interchromosomal homology-directed repair (HDR) mechanisms predominate. Here, using a Cas9 knock-in allele at the Spo11 locus, we show that meiotic expression of Cas9 does indeed mediate gene conversion in the male as well as in the female germline. However, the low frequency of both HDR and indel mutation in both male and female germlines suggests that Cas9 may be expressed from the Spo11 locus at levels too low for efficient DSB formation. We suggest that more robust Cas9 expression initiated during early meiosis I may improve the efficiency of gene conversion and further increase the rate of "super-mendelian" inheritance from both male and female mice.

Highlights

  • The mouse remains the single most utilized laboratory model of human physiology and disease

  • Using the same TyrCopyCat allele and crossing scheme to assess gene conversion efficiency as in our prior work [1], we demonstrate that Cas9 expression driven by Spo11 during meiosis I promotes gene conversion in the male as well as female germline

  • We hypothesized that restricting Cas9 expression to meiosis I in both the male and female germline should result in gene conversion events in both sexes

Read more

Summary

Introduction

The mouse remains the single most utilized laboratory model of human physiology and disease. Breeding strategies that combine multiple homozygous transgenic or knock-in alleles are cumbersome in mice due to small litter sizes and long generation times relative to other traditional model systems. Practical challenges limit the full potential for mouse genetic research to model certain complex human genetic disorders and to engineer models that better mimic human metabolism and immunity for therapeutic drug design. PLOS BIOLOGY available at Zenodo with the identifier 10.5281/ zenodo.5510697. Annotated sequence data for the Spo11Cas9-P2A-eGFP knock-in allele is available in GenBank with the accession number OK067273

Methods
Results
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.